Inhibition of vesicular stomatitis virus infection by nitric oxide - PubMed (original) (raw)

Inhibition of vesicular stomatitis virus infection by nitric oxide

Z Bi et al. J Virol. 1995 Apr.

Abstract

Inhibitory effects of nitric oxide (NO) on vesicular stomatitis virus (VSV) infection were investigated by using a VSV-susceptible mouse neuroblastoma cell line, NB41A3. Productive VSV infection of NB41A3 cells was significantly inhibited by an organic NO donor, S-nitro-N-acetylpenicillamine (SNAP), while the control compound N-acetylpenicillamine (NAP) had no effect. Survival rate of VSV-infected cells was greatly increased by the treatment with SNAP, while the NAP treatment did not have any effect. Adding SNAP 30 min prior to infection resulted in complete inhibition of viral production when a low multiplicity of infection (MOI) was used. Substantial inhibition of viral production was also obtained with treating cells 6 h earlier before infection with a higher MOI. Activating the neuronal NO synthase by treating cells with N-methyl-D-aspartate (NMDA) led to significant inhibition of viral production by cells infected at the three doses of virus tested (MOIs of 0.1, 1, and 5). The inhibitory effect of NMDA on viral infection was totally blocked by the NO synthase inhibitor N-methyl-L-arginine. However, adding hemoglobin, a strong NO-binding protein and thus an inactivator of NO activity, did not reverse the NMDA-induced inhibition of viral production, suggesting that NO might exert its antiviral effects inside the NO-producing cells. Collectively, these data support the anti-VSV effects of NO, which might be one of the important factors of natural immunity in controlling the initial stages of VSV infection in the central nervous system.

PubMed Disclaimer

Similar articles

• Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication.
  Lin YL, Huang YL, Ma SH, Yeh CT, Chiou SY, Chen LK, Liao CL. Lin YL, et al. J Virol. 1997 Jul;71(7):5227-35. doi: 10.1128/JVI.71.7.5227-5235.1997. J Virol. 1997. PMID: 9188590 Free PMC article.
• VSV replication in neurons is inhibited by type I IFN at multiple stages of infection.
  Trottier MD Jr, Palian BM, Reiss CS. Trottier MD Jr, et al. Virology. 2005 Mar 15;333(2):215-25. doi: 10.1016/j.virol.2005.01.009. Virology. 2005. PMID: 15721356
• Effects of nitric oxide availability on responses of spinal wide dynamic range neurons to excitatory amino acids.
  Budai D, Wilcox GL, Larson AA. Budai D, et al. Eur J Pharmacol. 1995 May 4;278(1):39-47. doi: 10.1016/0014-2999(95)00100-y. Eur J Pharmacol. 1995. PMID: 7545123
• Interferon-gamma-induced inhibition of neuronal vesicular stomatitis virus infection is STAT1 dependent.
  Chesler DA, Dodard C, Lee GY, Levy DE, Reiss CS. Chesler DA, et al. J Neurovirol. 2004 Feb;10(1):57-63. doi: 10.1080/13550280490261707. J Neurovirol. 2004. PMID: 14982729
• SNAP@CQD as a promising therapeutic vehicle against HCoVs: An overview.
  Chatterjee S, Chakraborty A, Banik J, Mahindru S, Sharma AK, Mukherjee M. Chatterjee S, et al. Drug Discov Today. 2023 Jul;28(7):103601. doi: 10.1016/j.drudis.2023.103601. Epub 2023 Apr 28. Drug Discov Today. 2023. PMID: 37119964 Free PMC article. Review.

Cited by

• Nitric oxide and viral infection: Recent developments in antiviral therapies and platforms.
  Garren MR, Ashcraft M, Qian Y, Douglass M, Brisbois EJ, Handa H. Garren MR, et al. Appl Mater Today. 2021 Mar;22:100887. doi: 10.1016/j.apmt.2020.100887. Epub 2020 Dec 5. Appl Mater Today. 2021. PMID: 38620577 Free PMC article. Review.
• Transcriptome analysis of salivary glands of rabies-virus-infected mice.
  Guo X, Zhang M, Feng Y, Liu X, Wang C, Zhang Y, Wang Z, Zhang D, Guo Y. Guo X, et al. Front Microbiol. 2024 Feb 6;15:1354936. doi: 10.3389/fmicb.2024.1354936. eCollection 2024. Front Microbiol. 2024. PMID: 38380102 Free PMC article.
• The Potential Role of Nitric Oxide as a Therapeutic Agent against SARS-CoV-2 Infection.
  Xiao S, Yuan Z, Huang Y. Xiao S, et al. Int J Mol Sci. 2023 Dec 5;24(24):17162. doi: 10.3390/ijms242417162. Int J Mol Sci. 2023. PMID: 38138990 Free PMC article. Review.
• Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia.
  Zhang H, Zhang C, Hua W, Chen J. Zhang H, et al. Med Gas Res. 2024 Apr-Jun;14(2):39-47. doi: 10.4103/2045-9912.385414. Med Gas Res. 2024. PMID: 37929506 Free PMC article. Review.
• Critical role of nitric oxide in impeding COVID-19 transmission and prevention: a promising possibility.
  Rajendran R, Chathambath A, Al-Sehemi AG, Pannipara M, Unnikrishnan MK, Aleya L, Raghavan RP, Mathew B. Rajendran R, et al. Environ Sci Pollut Res Int. 2022 Jun;29(26):38657-38672. doi: 10.1007/s11356-022-19148-4. Epub 2022 Mar 8. Environ Sci Pollut Res Int. 2022. PMID: 35258738 Free PMC article. Review.

References

1. 1. J Neurosci Res. 1994 Feb 15;37(3):406-14 - PubMed
2. 1. Brain Res. 1994 Jan 28;635(1-2):81-95 - PubMed
3. 1. J Exp Med. 1994 Jul 1;180(1):365-9 - PubMed
4. 1. Science. 1994 Jun 24;264(5167):1918-21 - PubMed
5. 1. Science. 1994 Jun 24;264(5167):1921-4 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Research Materials

  • NCI CPTC Antibody Characterization Program